Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Medicinal Chemistry
|
March 31, 2006
Similarity based virtual screening: a tool for targeted library design
Joni K O Alvesalo, Antti Siiskonen, Mikko J Vainio, et al.
Biochemical Pharmacology
|
July 10, 2010
Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae
Olli Salin, Sami Alakurtti, Leena Pohjala, et al.
Chemmedchem
|
May 8, 2007
Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifolol
Ingo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Chemistry of Materials : a Publication of the American Chemical Society
|
December 6, 2016
Efficient Light-Induced Phase Transitions in Halogen-Bonded Liquid Crystals
Francisco Fernandez-Palacio, Mikko Poutanen, Marco Saccone, et al.
Communications Materials
|
October 7, 2024
Strategies to control humidity sensitivity of azobenzene isomerisation kinetics in polymer thin films
Sami Vesamäki, Henning Meteling, Roshan Nasare, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae
Leena Keurulainen, Olli Salin, Antti Siiskonen, et al.
Journal of Medicinal Chemistry
|
May 4, 2007
Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives
Ingo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2015
Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani
Leena Keurulainen, Antti Siiskonen, Abedelmajeed Nasereddin, et al.
Journal of Medicinal Chemistry
|
April 24, 2015
A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides
Leena Keurulainen, Mikko Vahermo, Margarita Puente-Felipe, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Medicinal Chemistry
|
March 31, 2006
Similarity based virtual screening: a tool for targeted library design
Joni K O Alvesalo, Antti Siiskonen, Mikko J Vainio, et al.
Biochemical Pharmacology
|
July 10, 2010
Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae
Olli Salin, Sami Alakurtti, Leena Pohjala, et al.
Chemmedchem
|
May 8, 2007
Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifolol
Ingo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Chemistry of Materials : a Publication of the American Chemical Society
|
December 6, 2016
Efficient Light-Induced Phase Transitions in Halogen-Bonded Liquid Crystals
Francisco Fernandez-Palacio, Mikko Poutanen, Marco Saccone, et al.
Communications Materials
|
October 7, 2024
Strategies to control humidity sensitivity of azobenzene isomerisation kinetics in polymer thin films
Sami Vesamäki, Henning Meteling, Roshan Nasare, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae
Leena Keurulainen, Olli Salin, Antti Siiskonen, et al.
Journal of Medicinal Chemistry
|
May 4, 2007
Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives
Ingo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2015
Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani
Leena Keurulainen, Antti Siiskonen, Abedelmajeed Nasereddin, et al.
Journal of Medicinal Chemistry
|
April 24, 2015
A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides
Leena Keurulainen, Mikko Vahermo, Margarita Puente-Felipe, et al.
Page
of 2